Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence

Drug and Alcohol Dependence

Volumn 144, Issue , 2014, Pages 153-159

  Viola, Thiago Wendt ^a   Tractenberg, Saulo Gantes ^a   Wearick Silva, Luis Eduardo ^a   Rosa, Caroline Silva de Oliveira ^a   Pezzi, Júlio Carlos ^b   Grassi Oliveira, Rodrigo ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Addictive behavior; Adolescent; Cannabis; Cocaine; Hospitalization; Substance withdrawal syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; MOOD STABILIZER; NEUROLEPTIC AGENT; COCAINE;

ADDICTION SEVERITY INDEX 6; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; CLINICAL ASSESSMENT TOOL; COCAINE DEPENDENCE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DETOXIFICATION; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOOD DISORDER; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; SYMPTOM; WITHDRAWAL SYNDROME; COCAINE-RELATED DISORDERS; MARIJUANA ABUSE; MENTAL HEALTH SERVICE; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; TIME; TRENDS; YOUNG ADULT;

CANNABIS;

ADULT; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MARIJUANA ABUSE; MENTAL HEALTH SERVICES; PATIENT READMISSION; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 84908869563     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.09.003     Document Type: Article

References (41)

1. Abdalla R.R., Madruga C.S., Ribeiro M., Pinsky I., Caetano R., Laranjeira R. Prevalence of cocaine use in Brazil: data from the II Brazilian National Alcohol and Drugs Survey (BNADS). Addict. Behav. 2014, 39:297-301.
2. Aharonovich E., Garawi F., Bisaga A., Brooks D., Raby W.N., Rubin E., Nunes E.V., Levin F.R. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am. J. Drug Alcohol Abuse 2006, 32:629-635. 10.1080/00952990600919005.
3. Aharonovich E., Liu X., Samet S., Nunes E., Waxman R., Hasin D. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am. J. Psychiatry 2005, 162:1507-1514. 10.1176/appi.ajp.162.8.1507.
4. Ahmadi J., Kampman K., Dackis C., Sparkman T., Pettinati H. Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients. Am. J. Addict. 2008, 17:60-64. 10.1080/10550490701755999.
5. Alessi S.M., Rash C., Petry N.M. Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use. Drug Alcohol Depend. 2011, 118:62-67. 10.1016/j.drugalcdep.2011.03.001.
6. Babor T.F., Hofmann M., DelBoca F.K., Hesselbrock V., Meyer R.E., Dolinsky Z.S., Rounsaville B. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch. Gen. Psychiatry 1992, 49:599-608.
7. Becker J.B., Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008, 29:36-47. 10.1016/j.yfrne.2007.07.003.
8. Becker J.B., Perry A.N., Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol. Sex Differ. 2012, 3:14. 10.1186/2042-6410-3-14.
9. Calabria B., Degenhardt L., Hall W., Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev. 2010, 29:318-330. 10.1111/j.1465-3362.2009.00149.x.
10. Chadwick B., Miller M.L., Hurd Y.L. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front. Psychiatry 2013, 4:129. 10.3389/fpsyt.2013.00129.
11. De Bellis M.D., Wang L., Bergman S.R., Yaxley R.H., Hooper S.R., Huettel S.A. Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder. Drug Alcohol Depend. 2013, 133:134-145. 10.1016/j.drugalcdep.2013.05.020.
12. Del-Ben C.M., Vilela J.A., Crippa J.A., Hallak J.E.C., Labati C.M., Zuardi A.W. Reliability of the structured clinical interview for dsm-iv-clinical version translated into portuguese. Braz. J. Psychiatry 2001, 23:156-159.
13. Dluzen D.E., McDermott J.L. Sex differences in dopamine- and vesicular monoamine-transporter functions. Ann. N.Y. Acad. Sci. 2008, 1139:140-150. 10.1196/annals.1432.010.
14. Elman I., Karlsgodt K.H., Gastfriend D.R. Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug Alcohol Abuse 2001, 27:193-202.
15. Fattore L., Altea S., Fratta W. Sex differences in drug addiction: a review of animal and human studies. Womens Health (London Engl.) 2008, 4:51-65. 10.2217/17455057.4.1.51.
16. Fergusson D.M., Boden J.M. Cannabis use and later life outcomes. Addiction 2008, 103:969-976. (discussion 977-968). 10.1111/j.1360-0443.2008.02221.x.
17. Fergusson D.M., Boden J.M., Horwood L.J. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006, 101:556-569. 10.1111/j.1360-0443.2005.01322.x.
18. Fox H.C., Tuit K.L., Sinha R. Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine. Hum. Psychopharmacol. 2013, 28:40-53. 10.1002/hup.2280.
19. Francke I.D., Viola T.W., Tractenberg S.G., Grassi-Oliveira R. Childhood neglect and increased withdrawal and depressive severity in crack cocaine users during early abstinence. Child Abuse Negl. 2013, 37:883-889. 10.1016/j.chiabu.2013.04.008.
20. Hall W.D., Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 2005, 24:39-48. 10.1080/09595230500126698.
21. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
22. Hernandez G., Oleson E.B., Gentry R.N., Abbas Z., Bernstein D.L., Arvanitogiannis A., Cheer J.F. Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates. Biol. Psychiatry 2013, 75:487-498. 10.1016/j.biopsych.2013.09.005.
23. Johnston L.D., O'Malley P.M., Bachman J.G. Monitoring the Future National Survey Results on Drug Use, 1975-2003. Volume I: Secondary School Students National Institute on Drug Abuse 2004, NIH Publications, (04-5507-5504-5508).
24. Kampman K.M., Alterman A.I., Volpicelli J.R., Maany I., Muller E.S., Luce D.D., Mulholland E.M., Jawad A.F., Parikh G.A., Mulvaney F.D., Weinrieb R.M., O'Brien C.P. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol. Addict. Behav. 2001, 15:52-59.
25. Kampman K.M., Pettinati H.M., Volpicelli J.R., Oslin D.M., Lipkin C., Sparkman T., O'Brien C.P. Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. Am. J. Addict. 2004, 13:74-82.
26. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23:449-461.
27. Kessler F., Cacciola J., Alterman A., Faller S., Souza-Formigoni M.L., Santos Cruz M., Brasilliano S., Pechansky F. Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Rev. Bras. Psiquiatr. 2012, 34:24-33. S1516-44462012000100006 [pii].
28. Lucas P. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. J. Psychoactive Drugs 2012, 44:125-133.
29. Lynskey M.T., Heath A.C., Bucholz K.K., Slutske W.S., Madden P.A., Nelson E.C., Statham D.J., Martin N.G. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003, 289:427-433.
30. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J. Nerv. Ment. Dis. 1980, 168:26-33.
31. Moss H.B., Chen C.M., Yi H.Y. Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample. Drug Alcohol Depend. 2014, 136:51-62. Epub 2013 Dec 31. 10.1016/j.drugalcdep.2013.12.011.
32. Murray H.E., Pillai A.V., McArthur S.R., Razvi N., Datla K.P., Dexter D.T., Gillies G.E. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 2003, 116:213-222.
33. Orio L., Edwards S., George O., Parsons L.H., Koob G.F. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J. Neurosci. 2009, 29:4846-4857. 10.1523/JNEUROSCI.0563-09.2009.
34. Robinson S.M., Sobell L.C., Sobell M.B., Leo G.I. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol. Addict. Behav. 2014, 28:154-162. 10.1037/a0030992.
35. Sintov N.D., Kendler K.S., Walsh D., Patterson D.G., Prescott C.A. Predictors of illicit substance dependence among individuals with alcohol dependence. J. Stud. Alcohol Drugs 2009, 70:269-278.
36. Trape S., Charles-Nicolas A., Jehel L., Lacoste J. Early cannabis use is associated with severity of cocaine-induced psychosis among cocaine smokers in Martinique, French West Indies. J. Addict. Med. 2014, 8:33-39. 10.1097/ADM.0000000000000003.
37. Trenz R.C., Scherer M., Harrell P., Zur J., Sinha A., Latimer W. Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users. Addict. Behav. 2012, 37:367-372. 10.1016/j.addbeh.2011.11.011.
38. Volkow N.D., Baler R.D. Addiction science: uncovering neurobiological complexity. Neuropharmacology 2014, 76 Pt B:235-249. 10.1016/j.neuropharm.2013.05.007.
39. Wagner F.A., Anthony J.C. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002, 26:479-488. 10.1016/S0893-133X(01)00367-0.
40. Wilson J., Hernández-Hall C. The thermal coefficient of linear expansion. Physics Laboratory Experiments 2009, Cengage Learning, New York, NY, (251 pp.). J. Wilson, C. Hernández-Hall (Eds.).
41. Wiskerke J., Pattij T., Schoffelmeer A.N., De Vries T.J. The role of CB1 receptors in psychostimulant addiction. Addict. Biol. 2008, 13:225-238. 10.1111/j.1369-1600.2008.00109.x.